Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Filings indexed 2,283 across all filing types
Latest filing 2026-05-15 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
关于控股股东部分股份质押及解除质押的公告
Regulatory Filings Classification · 83% confidence The document is an announcement by the company concerning the pledge and release of share collateral by its controlling shareholder. It details the number of shares pledged, released, and outstanding, along with dates and counterparties. This is neither a financial report, dividend notice, securities issuance, nor an earnings release; it’s a regulatory disclosure specific to share pledges by a major shareholder. It does not report changes in ownership percentages but rather the status of pledged shares. It therefore does not match categories like MRQ, DIRS, POS, or CAP. As a miscellaneous regulatory filing that does not fit another category, it is best classified under Regulatory Filings (RNS).
2026-05-15 Chinese
关于与专业投资机构共同投资设立并购产业基金备案完成的进展公告
Regulatory Filings
2026-05-07 Chinese
2025年度权益分派实施公告
Regulatory Filings
2026-05-07 Chinese
关于召开2025年年度股东会的通知
Regulatory Filings
2026-03-30 Chinese
中国银河证券股份有限公司关于瑞普生物股份有限公司2025年度募集资金存放、管理与使用情况专项报告的核查意见
Regulatory Filings
2026-03-30 Chinese
关于对会计师事务所2025年度履职情况的评估报告
Regulatory Filings
2026-03-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.